BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18395147)

  • 1. Care of the adult Hodgkin lymphoma survivor.
    Thompson CA; Mauck K; Havyer R; Bhagra A; Kalsi H; Hayes SN
    Am J Med; 2011 Dec; 124(12):1106-12. PubMed ID: 22114824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phillips NS, Mulrooney DA, Williams AM, et al. Neurocognitive impairment associated with chronic morbidity in long-term survivors of Hodgkin Lymphoma. Blood Adv. 2023;7(23):7270-7278.
    Blood Adv; 2024 May; 8(10):2398-2399. PubMed ID: 38758562
    [No Abstract]   [Full Text] [Related]  

  • 3. The Need for an Early Biomarker of Cardiovascular Disease in Survivors of Hodgkin Lymphoma.
    Ness KK
    JACC CardioOncol; 2021 Jun; 3(2):274-276. PubMed ID: 34396334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review by the Fondazione Italiana Linfomi.
    Nassi L; De Sanctis V; Loseto G; Gerardi C; Allocati E; Ciavarella S; Minoia C; Guarini A; Bari A
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta-analysis.
    Boyne DJ; Mickle AT; Brenner DR; Friedenreich CM; Cheung WY; Tang KL; Wilson TA; Lorenzetti DL; James MT; Ronksley PE; Rabi DM
    Cancer Med; 2018 Sep; 7(9):4801-4813. PubMed ID: 30112841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
    van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
    Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-Related Fatigue and Muscle Quality in Hodgkin's Lymphoma Survivors.
    de Lima FD; Bottaro M; de Oliveira Valeriano R; Cruz L; Battaglini CL; Vieira CA; de Oliveira RJ
    Integr Cancer Ther; 2018 Jun; 17(2):299-305. PubMed ID: 28617061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Imaging with Cardiac Computed Tomography in Cardio-Oncology Patients.
    Pitekova B; Ravi S; Shah SV; Mladosievicova B; Heitner S; Ferencik M
    Curr Cardiol Rep; 2016 Sep; 18(9):87. PubMed ID: 27443383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility in female survivors of Hodgkin's lymphoma.
    Biasoli I; Falorio S; Luminari S; Spector N; Federico M
    Rev Bras Hematol Hemoter; 2012; 34(1):48-53. PubMed ID: 23049384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate surveillance for late complications in patients in remission from Hodgkin lymphoma.
    Darrington DL; Vose JM
    Curr Hematol Malig Rep; 2012 Sep; 7(3):200-7. PubMed ID: 22743837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients.
    Milano MT; Li H; Constine LS; Travis LB
    J Thorac Dis; 2012 Feb; 4(1):22-9. PubMed ID: 22295164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study.
    Milano MT; Li H; Gail MH; Constine LS; Travis LB
    J Clin Oncol; 2010 Dec; 28(34):5088-96. PubMed ID: 20975072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival patterns in patients with Hodgkin's lymphoma with a pre-existing hospital discharge diagnosis of autoimmune disease.
    Landgren O; Pfeiffer RM; Kristinsson SY; Björkholm M
    J Clin Oncol; 2010 Dec; 28(34):5081-7. PubMed ID: 20940191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan.
    Itoh K; Kinoshita T; Watanabe T; Yoshimura K; Okamoto R; Chou T; Ogura M; Hirano M; Asaoku H; Kurosawa M; Maeda Y; Omachi K; Moriuchi Y; Kasai M; Ohnishi K; Takayama N; Morishima Y; Tobinai K; Kaba H; Yamamoto S; Fukuda H; Kikuchi M; Yoshino T; Matsuno Y; Hotta T; Shimoyama M
    Int J Hematol; 2010 Apr; 91(3):446-55. PubMed ID: 20198461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helical tomotherapy in the radiotherapy treatment of Hodgkin's disease - a feasibility study.
    Vlachaki MT; Kumar S
    J Appl Clin Med Phys; 2010 Jan; 11(1):3042. PubMed ID: 20160691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin lymphoma: the follow-up of long-term survivors.
    Hodgson DC
    Hematol Oncol Clin North Am; 2008 Apr; 22(2):233-44, vi. PubMed ID: 18395147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
    Aleman BM; van Leeuwen FE
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):961-75. PubMed ID: 17908631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second cancers in survivors of hodgkin lymphoma: risks and recommendations.
    Leahy Y
    Clin J Oncol Nurs; 2008 Jun; 12(3):437-42. PubMed ID: 18515242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects.
    Hodgson DC; Grunfeld E; Gunraj N; Del Giudice L
    Cancer; 2010 Jul; 116(14):3417-25. PubMed ID: 20564062
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.